Skip to main
SHC

Sotera Health (SHC) Stock Forecast & Price Target

Sotera Health (SHC) Analyst Ratings

Based on 7 analyst ratings
Buy
Strong Buy 29%
Buy 57%
Hold 14%
Sell 0%
Strong Sell 0%

Bulls say

Sotera Health is expected to see continued growth in all three segments, with management demonstrating strong leadership through a strategic planning process and an emphasis on talent, customer partnerships, and cross-business offerings. With a solid start to 2026 and the CEO succession plan being well-managed, the company is poised for strong performance and growth consistency, making it a good investment opportunity at current levels.

Bears say

Sotera Health is facing several legal challenges, including a recent settlement for an "immaterial" amount in a New Mexico public nuisance case, and ongoing trials in Georgia and California. While management remains confident in their litigate-with-science and settle modestly strategy, the continuous legal risks and potential financial implications for the company may weigh on the stock's valuation. Additionally, while the company's Sterigenics segment has shown growth, intensive competition in the industry and potential regulatory hurdles could impede future growth prospects.

Sotera Health (SHC) has been analyzed by 7 analysts, with a consensus rating of Buy. 29% of analysts recommend a Strong Buy, 57% recommend Buy, 14% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Sotera Health and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Sotera Health (SHC) Forecast

Analysts have given Sotera Health (SHC) a Buy based on their latest research and market trends.

According to 7 analysts, Sotera Health (SHC) has a Buy consensus rating as of Aug 14, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $21.86, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $21.86, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Sotera Health (SHC)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.